• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Governor signs GA HB 235 into law


The new Georgia law allows ODs to prescribe steroids, hydracodone, and all medications using any distribution method except surgical or injectable, plus requires all ODs to take CE regardless of age.

Atlanta, GA-Georgia governor Nathan Deal (R) yesterday signed into law HB 235. The new law is effective immediately and:
• Allows optometrists to prescribe corticosteroids for up to 14 days.
• Allows optometrists to prescribe hydrocodone for up to 48 hours regardless of any changes to federal reclassification of the medication.
• Allows optometrists to prescribe all medication using any appropriate distribution method except surgical or injectable, including any new vehicles to administer medications, such as nasal sprays, contact lenses, etc.
• Requires all optometrists to take continuing education regardless of age.

Related Videos
Andy Morgenstern, OD, FAAO, FNAP chats with Optometry Times
R Tracy Williams, OD, FAAO with Optometry Times
Shan Lin, MD, speaks on Glaucoma 360 presentation in an interview with Ophthalmology Times
Cecelia Koetting, OD, FAAO, DIPABO, left, speaks with Optometry Times about the 2024 EnVision Summit
Bonnie An Henderson, MD, highlights key takeaways of the 2024 EnVision Summit, including diversity and family inclusion
Danica Marrelli, OD, FAAO, AAO Dipl, co-chair of EnVision Summit chats about geographic atrophy and glaucoma panels
Robert Weiss, former CEO and President of The Cooper Companies, Inc. (left) and Optometry Times' Assistant Managing Editor Emily Kaiser Maharjan Image Credit ©Optometry Times
© 2024 MJH Life Sciences

All rights reserved.